As of March 23, 2026, RenovoRx's top three insider holders are Ramtin Agah (Chief Medical Officer, 975.00K shares), Ramtin Agah (Chief Medical Officer, 798.46K shares), Shaun Bagai (Chief Executive Officer, 340.04K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Ramtin Agah | Chief Medical Officer | 0 | 975,000 | 08 Jun, 2022 |
| Ramtin Agah | Chief Medical Officer | 798,460 | 0 | 22 Jan, 2026 |
| Shaun Bagai | Chief Executive Officer | 340,040 | 0 | 22 Dec, 2025 |
| Laurence Marton | 66,164 | 0 | 06 May, 2025 | |
| Robert J. Spiegel | 40,983 | 0 | 30 Jan, 2024 | |
| K. Angela Macfarlane | 40,983 | 0 | 30 Jan, 2024 | |
| Ron Kocak | Vp Controller And Pao | 12,595 | 0 | 10 Apr, 2025 |
| Angela Nelms | Chief Operating Officer | 1,100 | 0 | 04 Oct, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 21 Jan, 2026 | Ramtin Agah | Common Stock | A | 10,000 | $1.00 | 798,460 | D | P |
| 31 Dec, 2025 | Ramtin Agah | Common Stock | A | 9,795 | $0.86 | 788,460 | D | P |
| 30 Dec, 2025 | Ramtin Agah | Common Stock | A | 205 | $0.83 | 778,665 | D | P |
| 18 Dec, 2025 | Shaun Bagai | Common Stock | A | 5,000 | $0.90 | 340,040 | D | P |
| 17 Dec, 2025 | Shaun Bagai | Common Stock | A | 5,000 | $0.85 | 335,040 | D | P |
| 16 Dec, 2025 | Ramtin Agah | Common Stock | A | 12,000 | $0.85 | 778,460 | D | P |
| 05 Dec, 2025 | Ramtin Agah | Common Stock | A | 10,000 | $0.96 | 766,460 | D | P |
| 21 Nov, 2025 | Ramtin Agah | Common Stock | A | 10,000 | $0.80 | 744,460 | D | P |
| 24 Nov, 2025 | Ramtin Agah | Common Stock | A | 12,000 | $0.80 | 756,460 | D | P |
| 01 Oct, 2025 | Laurence Marton | Stock Options (right to buy) | A | 47,640 | $0.00 | 47,640 | D | A |
| 01 Oct, 2025 | K. Angela Macfarlane | Stock Options (right to buy) | A | 47,640 | $0.00 | 47,640 | D | A |
| 01 Oct, 2025 | Robert J. Spiegel | Stock Options (right to buy) | A | 47,640 | $0.00 | 47,640 | D | A |
| 22 Aug, 2025 | Shaun Bagai | Common Stock | A | 5,000 | $0.95 | 325,040 | D | P |
| 25 Aug, 2025 | Shaun Bagai | Common Stock | A | 5,000 | $0.91 | 330,040 | D | P |
| 01 Jul, 2025 | Ron Kocak | Stock Option | A | 41,600 | $0.00 | 41,600 | D | A |
| 01 Jul, 2025 | Shaun Bagai | Stock Option | A | 102,498 | $0.00 | 102,498 | D | A |
| 01 Jul, 2025 | Leesa Gentry | Stock Option | A | 6,619 | $0.00 | 6,619 | D | A |
| 01 Jul, 2025 | Ramtin Agah | Stock Option | A | 63,636 | $0.00 | 63,636 | D | A |
| 05 Jun, 2025 | Ramtin Agah | Common Stock | A | 21,000 | $1.40 | 734,460 | D | P |
| 22 Apr, 2025 | Ramtin Agah | Common Stock | D | 400,000 | $0.00 | 713,460 | D | G |